Family history of breast cancer and risk of benign breast diseases
an integrative literature review
Keywords:
breast diseases, fibrocystic breast disease, breast neoplasmsAbstract
Introduction: Some benign breast diseases (BBD) can determine an increased risk of developing breast cancer. Environmental factors related to lifestyle and family history of breast cancer may be associated with BBD development. However, the effect of family history of breast cancer on the risk of benign breast diseases is still unclear. Objective: To evaluate the association between family history of breast cancer and benign breast diseases. Methods: This is an integrative review that selected observational studies in different databases to analyze the association between BBD and family history of breast cancer, considering the different classification criteria for both benign diseases and family history. All studies were published between 1977 and 2016. A total of 13 studies were selected, among which ten are case-control and case-cohort studies; and three are cohort studies. Most studies received high or moderate quality classification according to the Newcastle-Ottawa assessment scale. Results: Family history of breast cancer was associated with the development of proliferative lesions and the presence of atypia, and it was more closely related to the development of benign diseases in young women, with a tendency to decrease with advancing age. Conclusion: Studies suggest there may be an association between family history of breast cancer and benign breast diseases; nevertheless, no statistically significant results were found in many case-control studies, and more robust prospective research is necessary to further clarify this association.
Downloads
References
IARC. Working Group on the Evaluation of Cancer-Preventive. Breast Cancer Screening [Internet]. IARC; 2016 [accessed on Oct. 10, 2019]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016
Silverstein M. Where’s the Outrage? J Am Coll Surg; 2009;208(1):78- 9. https://doi.org/10.1016/j.jamcollsurg.2008.09.022
Gutwein LG, Ang DN, Liu H, Marshall JK, Hochwald SN, Copeland EM, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011;202(2):127-32. https://doi.org/10.1016/j.amjsurg.2010.09.005
Santen RJ, Mansel R. Benign Breast Disorders. N Engl J Med. 2005;353(3):275-85. https://doi.org/10.1056/NEJMra035692
Porter GJR, Evans AJ, Lee AHS, Hamilton LJ, James JJ. Unusual benign breast lesions. Clin Radiol. 2006;61(7):562-9. https://doi.org/10.1016/j.crad.2006.02.008
Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569-75. https://doi.org/10.1007/s10549-014-3254-6
Dupont WD, Page DL. Risk Factors for Breast Cancer in Women with Proliferative Breast Disease. N Engl J Med. 1985;312(3):146- 51. https://doi.org/10.1056/NEJM198501173120303
Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer. 2007;109(2):180-7. https://doi.org/10.1002/cncr.22408
Worsham MJ, Raju U, Lu M, Kapke A, Bottrell A, Cheng J, et al. Risk Factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009;118(1):1-7. https://doi.org/10.1007/s10549-008-0198-8
Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 2010;21(6):821-8. https://doi.org/10.1007/s10552-010-9508-7
Nutter EL, Weiss JE, Marotti JD, Barth Jr. RJ, Eliassen S, Goodrich ME, et al. Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer: Personal History of BBD and Risk of MFBC. Cancer. 2018;124(7):1350-7. https://doi.org/10.1002/cncr.31202
Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MPA, et al. Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast. Am J Pathol. 1999;155(6):1811- 5. https://dx.doi.org/10.1016%2FS0002-9440(10)65498-3
Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical Hyperplasia of the Breast — Risk Assessment and Management Options. N Engl J Med. 2015;372(1):78-89. https://doi.org/10.1056/NEJMsr1407164
Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57(2):171-92. https://doi.org/10.1111/j.1365-2559.2010.03568.x
Bombonati A, Sgroi DC. The Molecular Pathology of Breast Cancer Progression. J Pathol. 2011;223(2):308-18. https://doi.org/10.1002/path.2808
Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55(2):231-73.
Rohan TE, Miller AB. Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Cancer Prev. 1999;8(2):123-30. https://doi.org/10.1097/00008469-199904000-00006
Galván-Portillo M, Sanchez LT, López-Carrillo L. Dietary and reproductive factors associated with benign breast disease in Mexican women. Nutr Cancer. 2002;43(2):133-40. https://doi.org/10.1207/s15327914nc432_3
Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, et al. A Prospective Study of Diet and Benign Breast Disease. Cancer Epidemiol Prev Biomark. 2004;13(7):1106-13.
Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011;22(9):1297-305. https://doi.org/10.1007/s10552-011-9803-y
Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 2012;118(11):2796-803. https://doi.org/10.1002/cncr.26519
Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, et al. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002;100(3):375-8. https://doi.org/10.1002/ijc.10490
Wu C, Ray RM, Lin MG, Gao DL, Horner NK, Nelson ZC, et al. A Case-Control Study of Risk Factors for Fibrocystic Breast Conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol. 2004;160(10):945-60. https://doi.org/10.1093/aje/kwh318
Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015;47(4):373-80. https://doi.org/10.1038/ng.3242
Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, et al. Design and analysis issues in a populationbased, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 1999;(26):95-100. https://doi.org/10.1093/oxfordjournals. jncimonographs.a024232
De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health. 2012;2012:713696. https://doi.org/10.1155/2012/713696
Gray JM, Rasanayagam S, Engel C, Rizzo J. State of the evidence 2017: an update on the connection between breast cancer and the environment. Environ Health. 2017;16:94. https://doi.org/10.1186/s12940-017-0287-4
NCCN. Genetic/familial high-risk assessment: breast and ovarian. NCCN; 2018.
Zhou W-B, Xue D-Q, Liu X-A, Ding Q, Wang S. The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol. 2011;137(7):1053-60. https://doi.org/10.1007/s00432-011-0979-z
Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev. 1997;19(2):310-27. https://doi.org/10.1093/oxfordjournals.epirev.a017960
Silvera SAN, Rohan TE. Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat. 2008;110(3):397-409. https://doi.org/10.1007/s10549-007-9740-3
Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.100009711
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. 2019 [accessed on Oct. 11, 2019]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Ingram DM, Nottage E, Roberts T. The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer. 1991;64(1):187-91. https://doi.org/10.1038/bjc.1991.268
Catsburg C, Gunter MJ, Chen C, Cote ML, Kabat GC, Nassir R, et al. Insulin, Estrogen, Inflammatory Markers, and
Risk of Benign Proliferative Breast Disease. Cancer Res. 2014;74(12):3248-58. https://doi.org/10.1158/0008-5472.CAN-13-3514
Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NL, Kopans DB, et al. Histologic and mammographic specificity of risk factors for benign breast disease. Cancer. 1989;64(3):653-7.https://doi.org/10.1002/1097-0142(19890801)64:3<653::AIDCNCR2820640315>3.0.CO;2-O
Rohan TE, Jain M, Miller AB. A case-cohort study of diet and risk of benign proliferative epithelial disorders of the breast (Canada). Cancer Causes Control. 1998;9(1):19-27.
Conceição LL da, Dias MDM, Pessoa MC, Pena GG, Mendes MCS, Neves CVB, et al. Difference in fatty acids composition of breast adipose tissue in women with breast cancer and benign breast disease. Nutr Hosp. 2016;33(6):1354-60. https://doi.org/10.20960/nh.795
Hardy EE, Pinotti JA, Osis MJ, Faúndes A. Variáveis reprodutivas e risco para doenças benignas de mama: estudo
caso controle. Rev Saúde Pública. 1990;24(5):387-93. https://doi.org/10.1590/S0034-89101990000500006
Nomura A, Comstock GW, Tonascia JA. Epidemiologic characteristics of benign breast disease. Am J Epidemiol. 1977;105(6):505-12. https://doi.org/10.1093/oxfordjournals.aje. a112413
Hislop TG, Elwood JM. Risk factors for benign breast disease: a 30-year cohort study. Can Med Assoc J. 1981;124(3):283-91.
Minami Y, Ohuchi N, Taeda Y, Fukao A, Hisamichi S. Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer. Jpn J Cancer Res Gann. 1998;89(2):116-23. https://doi.org/10.1111/j.1349-7006.1998.tb00538.x
Bao P-P, Zheng Y, Wu C-X, Huang Z-Z, Gao Y-T, Jin F, et al. Cancer incidence in urban Shanghai, 1973-2010: an updated trend and age-period-cohort effects. BMC Cancer. 2016;16:284. https://doi.org/10.1186/s12885-016-2313-2
Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press; 2003.
Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017;18(12):1579-89. https://doi.org/10.1016/S1470-2045(17)30677-0
Sclowitz ML, Menezes AMB, Gigante DP, Tessaro S. Condutas na prevenção secundária do câncer de mama e fatores associados. Rev Saúde Pública. 2005;39(3):340-9. https://doi.org/10.1590/S0034-89102005000300003
Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA. 2011;305(23):2462-3. https://doi.org/10.1001/jama.2011.822
Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown and Co.; 1987.
Rothman KJ, Greenland S, Lash TL. Epidemiologia Moderna [Internet]. 3ª ed. Porto Alegre: Artmed; 2011 [accessed on Oct. 17, 2019]. Available from: https://www.livrariaflorence.com.br/produto/livro-epidemiologia-moderna-rothman-134984
Salamat F, Niakan B, Keshtkar A, Rafiei E, Zendehdel M. Subtypes of benign breast disease as a risk factor of breast cancer: A systematic review and meta analyses. Iran J Med Sci. 2018;43(4):355-64.
Zeinomar N, Phillips K-A, Daly MB, Milne RL, Dite GS, MacInnis RJ, et al. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort. Int J Cancer. 2019;145(2):370-9. https://doi.org/10.1002/ijc.32112
Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, et al. Genetic Variation and Circulating Levels of IGF-I and IGFBP-3 in Relation to Risk of Proliferative Benign Breast Disease. Int J Cancer. 2010;126(1):180-90. https://doi.org/10.1002/ijc.24674
Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, et al. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies. JNCI J Natl Cancer Inst. 2017;109(10):djx035. https://doi.org/10.1093/jnci/djx035
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Marla Presa Raulino Schilling, Ilce Ferreira da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
